|
|
xii | |
|
List of Tables in Appendices |
|
|
xv | |
Preface |
|
xvi | |
How to Use This Book |
|
xviii | |
How to Use StudyWare™ to Accompany Pharmacological Aspects of Nursing Care, 7th Edition |
|
xxii | |
NCLEX-PN and NCLEX-RN Test Plans |
|
xxx | |
|
SECTION 1 Introduction to Drugs and Drug Administration |
|
|
|
Drugs/Agents and Factors Affecting Their Action |
|
|
2 | (35) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
5 | (4) |
|
|
9 | (1) |
|
|
10 | (6) |
|
Canadian Drug Legislation |
|
|
16 | (1) |
|
Drug Information Resources |
|
|
16 | (1) |
|
|
17 | (2) |
|
Principles of Drug Action |
|
|
19 | (1) |
|
|
20 | (1) |
|
Pharmacokinetic Factors in Drug Therapy |
|
|
21 | (4) |
|
|
25 | (1) |
|
Individual Variation of Pharmacological Response |
|
|
26 | (1) |
|
|
27 | (1) |
|
Physical and Chemical Incompatibilities |
|
|
27 | (1) |
|
Herbals and Botanical Medicine |
|
|
27 | (10) |
|
Principles and Methods of Drug Administration |
|
|
37 | (36) |
|
The Nursing Process and Medication Administration |
|
|
37 | (2) |
|
Administering Medications |
|
|
39 | (24) |
|
Nursing Process in Client Teaching |
|
|
63 | (3) |
|
Fostering Compliance and Cooperation with Medication Regimens |
|
|
66 | (2) |
|
Nursing Process Approach to Improving Cooperation |
|
|
68 | (5) |
|
|
73 | (22) |
|
Intravenous Infusion Therapy |
|
|
74 | (5) |
|
Applying the Nursing Process |
|
|
79 | (7) |
|
Electronic Infusion Devices |
|
|
86 | (9) |
|
Calculating Medication Dosages |
|
|
95 | (17) |
|
Interpreting the Drug Prescriptions |
|
|
95 | (1) |
|
|
96 | (3) |
|
Conversion between Systems of Measurement |
|
|
99 | (3) |
|
Calculation of Fractional Doses |
|
|
102 | (1) |
|
Calculation of Dosages Based on Weight |
|
|
103 | (1) |
|
Pediatric Dosage Calculations |
|
|
104 | (1) |
|
Calculations Involving Intravenous Administration |
|
|
105 | (3) |
|
Calculations Related to Solutions |
|
|
108 | (1) |
|
Prevention of Medication Errors |
|
|
109 | (3) |
|
Drug Therapy for Pediatric Clients |
|
|
112 | (19) |
|
|
112 | (4) |
|
Applying the Nursing Process |
|
|
116 | (9) |
|
Nursing Children Receiving Medications |
|
|
116 | (9) |
|
|
125 | (1) |
|
|
126 | (5) |
|
Drug Therapy for Geriatric Clients |
|
|
131 | (13) |
|
|
131 | (3) |
|
Applying the Nursing Process |
|
|
134 | (10) |
|
Nursing Care of Elderly Clients Receiving Drug Therapy |
|
|
134 | (10) |
|
SECTION 2 Agents That Interfere with Microbial Growth |
|
|
|
|
144 | (75) |
|
Susceptibility of the Body to Infection |
|
|
144 | (2) |
|
|
146 | (2) |
|
Identification of the Infecting Organism |
|
|
148 | (1) |
|
Selection of Antimicrobial Agents |
|
|
148 | (2) |
|
Classification of Antimicrobial Agents |
|
|
150 | (1) |
|
|
151 | (1) |
|
|
152 | (26) |
|
Urinary Tract Anti-Infectives |
|
|
178 | (2) |
|
Drugs Used to Treat Tuberculosis |
|
|
180 | (1) |
|
Drugs Used to Treat Lyme Disease |
|
|
181 | (2) |
|
|
183 | (3) |
|
|
186 | (9) |
|
Miscellaneous Anti-Infective Agents |
|
|
195 | (1) |
|
|
195 | (1) |
|
Applying the Nursing Process |
|
|
196 | (14) |
|
Clients Receiving Penicillins |
|
|
199 | (2) |
|
Clients Receiving Cephalosporins |
|
|
201 | (1) |
|
Clients Receiving Tetracyclines |
|
|
201 | (1) |
|
Clients Receiving Aminoglycosides |
|
|
202 | (1) |
|
Clients Receiving Chemotherapy for Tuberculosis |
|
|
203 | (1) |
|
Clients Receiving Sulfonamides and Urinary Tract Anti-Infectives |
|
|
204 | (2) |
|
Clients Receiving Antifungal Agents |
|
|
206 | (1) |
|
Clients Receiving Antiviral Agents |
|
|
207 | (1) |
|
Clients with AIDS Receiving Drug Treatment |
|
|
208 | (2) |
|
Nursing Care Plan: A Client with Urinary Tract Infection Taking Trimethoprim/Sulfamethoxazole and Phenazopyridine HCl |
|
|
210 | (2) |
|
Nursing Care Plan: A Client with Acquired Immunodeficiency Syndrome |
|
|
212 | (7) |
|
Antiparasitic Drug Therapy |
|
|
219 | (20) |
|
|
219 | (1) |
|
Systemic Parasitic Infections |
|
|
220 | (1) |
|
Other Protozoal Infections |
|
|
221 | (4) |
|
Anthelmintic Agents and Intestinal Parasitic Disorders |
|
|
225 | (1) |
|
Dermatological Parasitic Disorders |
|
|
226 | (2) |
|
Applying the Nursing Process |
|
|
228 | (4) |
|
Clients Receiving Antimalarial Drugs |
|
|
228 | (1) |
|
Clients Receiving Drugs for Amebiasis and Trichomonal Infections |
|
|
229 | (1) |
|
Clients Receiving Anthelmintics |
|
|
230 | (1) |
|
Clients Receiving Drugs for Dermatological Parasites |
|
|
231 | (1) |
|
Nursing Care Plan: A Client with Pinworms Taking Thiabendazole (Mintezol) Suspension |
|
|
232 | (7) |
|
Antiseptics and Disinfectants |
|
|
239 | (19) |
|
|
240 | (5) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
Chlorhexidine (Hibiclens, Hibistat, Exidine) |
|
|
247 | (1) |
|
Applying the Nursing Process |
|
|
248 | (4) |
|
|
250 | (2) |
|
Nursing Care Plan: A Client with a Stage III Pressure Ulcer |
|
|
252 | (6) |
|
SECTION 3 Agents Used to Control Pain and Inflammation |
|
|
|
Analgesics and Antipyretics |
|
|
258 | (43) |
|
|
258 | (3) |
|
|
261 | (8) |
|
|
269 | (1) |
|
|
270 | (1) |
|
|
270 | (1) |
|
|
271 | (8) |
|
Applying the Nursing Process |
|
|
279 | (13) |
|
|
282 | (2) |
|
|
284 | (1) |
|
|
285 | (1) |
|
Client-Controlled Analgesia |
|
|
286 | (1) |
|
Client-Controlled Oral Analgesia |
|
|
287 | (1) |
|
|
288 | (2) |
|
Pain Management in End-of-Life Care |
|
|
290 | (2) |
|
Nursing Care Plan: A Client Receiving Morphine Sulfate Following Appendectomy |
|
|
292 | (2) |
|
Nursing Care Plan: A Client Receiving Morphine via Epidural Catheter Following Hysterectomy |
|
|
294 | (7) |
|
|
301 | (24) |
|
|
301 | (7) |
|
|
308 | (6) |
|
Applying the Nursing Process |
|
|
314 | (6) |
|
Clients with Malignant Hyperthermia |
|
|
316 | (1) |
|
Nursing Care Following General Anesthesia |
|
|
317 | (1) |
|
Safety and Anesthetic Agents |
|
|
318 | (1) |
|
Nursing Care Following Regional (Local) Anesthesia |
|
|
318 | (1) |
|
|
319 | (1) |
|
Nursing Care Plan: A Postsurgical Client |
|
|
320 | (5) |
|
|
325 | (27) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
326 | (4) |
|
Disease-Modifying Antirheumatic Drugs |
|
|
330 | (2) |
|
Slow-Acting Antirheumatic Agents |
|
|
332 | (1) |
|
|
333 | (7) |
|
Applying the Nursing Process |
|
|
340 | (6) |
|
Clients Receiving Nonsteroidal Anti-Inflammatory Agents |
|
|
340 | (2) |
|
Clients Receiving Drug-Modifying Antirheumatic Drugs |
|
|
342 | (1) |
|
Clients Receiving Slow-Acting Antirheumatic Drugs |
|
|
343 | (1) |
|
Clients Receiving Corticosteroids |
|
|
344 | (2) |
|
Nursing Care Plan: A Client with Arthritis Taking Adalimumab and Prednisone |
|
|
346 | (6) |
|
Agents Used to Treat Hyperuricemia and Gout |
|
|
352 | (12) |
|
Management of Acute Gouty Arthritis |
|
|
353 | (2) |
|
|
355 | (1) |
|
Applying the Nursing Process |
|
|
356 | (2) |
|
Nursing Care Plan: A Client with Hyperuricemia and Gout Taking Probenecid and Colchicine |
|
|
358 | (6) |
|
SECTION 4 Agents Used to Treat Respiratory Disorders |
|
|
|
Antihistamines and Nasal Decongestants |
|
|
364 | (18) |
|
|
365 | (1) |
|
|
366 | (7) |
|
Applying the Nursing Process |
|
|
373 | (3) |
|
Nursing Care Plan: A Client with a Cold Taking Pseudoephedrine Hydrochloride (Sudafed) |
|
|
376 | (6) |
|
Expectorant and Antitussive Agents |
|
|
382 | (11) |
|
|
382 | (1) |
|
|
383 | (1) |
|
Applying the Nursing Process |
|
|
383 | (5) |
|
Nursing Care Plan: A Child with Bronchitis Taking Guaifenesin (Robitussin) Syrup |
|
|
388 | (5) |
|
Bronchodilators and Other Respiratory Agents |
|
|
393 | (21) |
|
|
393 | (7) |
|
|
400 | (1) |
|
|
400 | (2) |
|
Applying the Nursing Process |
|
|
402 | (4) |
|
Nursing Care Plan: A Client with Asthma Using Cromolyn Sodium (Intal) and Terbutaline Sulfate (Brethine) |
|
|
406 | (8) |
|
SECTION 5 Agents Used to Treat Cardiovascular Disorders |
|
|
|
Cardiac Stimulants and Depressants |
|
|
414 | (28) |
|
|
416 | (3) |
|
Inamrinone Lactate (Inamrinone) and Milrinone Lactate (Primacor) |
|
|
419 | (1) |
|
Antiarrhythmic/Antidysrhythmic Agents |
|
|
419 | (9) |
|
Cardiac Stimulants Used to Treat Shock |
|
|
428 | (3) |
|
Applying the Nursing Process |
|
|
431 | (5) |
|
Clients Receiving Cardiac Glycosides |
|
|
431 | (3) |
|
Clients Receiving Antidysrhythmic Agents |
|
|
434 | (1) |
|
Clients in Cardiac Emergencies and Shock |
|
|
435 | (1) |
|
Nursing Care Plan: An Insulin-Dependent Client with Cardiac Antidysrhythmia Taking Amiodarone Hydrochloride (Cordarone) |
|
|
436 | (6) |
|
Agents That Dilate Blood Vessels |
|
|
442 | (19) |
|
|
442 | (5) |
|
|
447 | (3) |
|
|
450 | (1) |
|
Applying the Nursing Process |
|
|
450 | (4) |
|
Clients Receiving Coronary Vasodilators |
|
|
450 | (4) |
|
Nursing Care Plan: A Client with Angina Using Transdermal Nitroglycerin (Nitro-Dur) |
|
|
454 | (7) |
|
Clients Receiving Peripheral Vasodilators |
|
|
456 | (5) |
|
Agents Affecting Blood Clotting |
|
|
461 | (21) |
|
|
461 | (6) |
|
|
467 | (1) |
|
|
468 | (1) |
|
Tissue Plasminogen Activator |
|
|
469 | (1) |
|
|
469 | (1) |
|
|
469 | (1) |
|
Applying the Nursing Process |
|
|
470 | (6) |
|
Clients Receiving Anticoagulants |
|
|
470 | (2) |
|
|
472 | (2) |
|
|
474 | (1) |
|
Nursing Care Following Intracoronary Thrombolysis |
|
|
475 | (1) |
|
Nursing Care Plan: A Client with Acute Myocardial Infarction Receiving Alteplase (Activase), A Tissue Plasminogen Activator |
|
|
476 | (6) |
|
Diuretics and Antihypertensives |
|
|
482 | (32) |
|
|
482 | (6) |
|
|
488 | (13) |
|
Applying the Nursing Process |
|
|
501 | (7) |
|
Meeting Sodium and Potassium Needs |
|
|
502 | (1) |
|
|
503 | (2) |
|
Long-Term Client Management |
|
|
505 | (2) |
|
Management of Hypertensive Emergencies |
|
|
507 | (1) |
|
Nursing Care Plan: A Client with Hypertension Taking Enalapril Maleate (Vasotec), Hydrochlorothiazide |
|
|
508 | (6) |
|
Agents Used in the Treatment of Hyperlipidemia |
|
|
514 | (12) |
|
|
514 | (5) |
|
Applying the Nursing Process |
|
|
519 | (1) |
|
Nursing Care Plan: A Client with Hyperlipidemia Receiving Simvastatin (Zocor) |
|
|
520 | (6) |
|
Agents Used to Treat Anemias |
|
|
526 | (13) |
|
|
527 | (2) |
|
|
529 | (3) |
|
Applying the Nursing Process |
|
|
532 | (2) |
|
Nursing Care Plan: A Client with Crohn's Disease Taking Vitamin B12 |
|
|
534 | (5) |
|
Vitamins, Minerals, and Other Nutritional Agents |
|
|
539 | (25) |
|
|
540 | (3) |
|
|
543 | (1) |
|
|
544 | (1) |
|
|
544 | (3) |
|
|
547 | (5) |
|
Total Parenteral Nutrition |
|
|
552 | (1) |
|
Applying the Nursing Process |
|
|
553 | (3) |
|
Nursing Care Plan: A Client with Congestive Heart Failure Receiving a Diuretic with a Potassium Supplement |
|
|
556 | (8) |
|
SECTION 6 Agents Used to Treat Gastrointestinal Disorders |
|
|
|
Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease |
|
|
564 | (21) |
|
|
565 | (4) |
|
Histamine H2 Receptor Antagonists |
|
|
569 | (1) |
|
|
570 | (1) |
|
|
571 | (1) |
|
|
571 | (1) |
|
Metoclopramide (Reglan, Emex) |
|
|
571 | (1) |
|
|
572 | (1) |
|
Applying the Nursing Process |
|
|
572 | (6) |
|
Nursing Clients Taking Antacids |
|
|
572 | (3) |
|
Nursing Clients Receiving Histamine H2 Receptor Antagonists, Proton Pump Inhibitors, and Sucralfate |
|
|
575 | (1) |
|
Nursing Clients Taking Metoclopramide |
|
|
576 | (2) |
|
Nursing Care Plan: A Client with Peptic Ulcer Disease Taking Antacids |
|
|
578 | (2) |
|
Nursing Care Plan: A Client with Hiatal Hernia Taking Metoclopramide (Reglan) and Esomeprazole Magnesium (Nexium) |
|
|
580 | (5) |
|
|
585 | (11) |
|
|
585 | (1) |
|
|
586 | (4) |
|
Applying the Nursing Process |
|
|
590 | (6) |
|
|
590 | (1) |
|
Clients Taking Antiemetics |
|
|
591 | (5) |
|
Laxatives and Antidiarrheals |
|
|
596 | (18) |
|
|
596 | (6) |
|
|
602 | (2) |
|
Applying the Nursing Process |
|
|
604 | (10) |
|
Clients Receiving Laxatives |
|
|
604 | (3) |
|
Clients Receiving Antidiarrheal Agents |
|
|
607 | (7) |
|
SECTION 7 Agents Affecting the Nervous System |
|
|
|
Central Nervous System Sedatives and Hypnotics |
|
|
614 | (18) |
|
|
614 | (3) |
|
|
617 | (2) |
|
|
619 | (1) |
|
|
620 | (1) |
|
|
620 | (2) |
|
Applying the Nursing Process |
|
|
622 | (4) |
|
Clients Receiving Sedative-Hypnotics |
|
|
622 | (1) |
|
Clients Receiving Barbiturates |
|
|
623 | (1) |
|
Clients Receiving Nonbarbiturates |
|
|
624 | (2) |
|
Nursing Care Plan: A Client with Anxiety Taking Diazepam (Valium) |
|
|
626 | (6) |
|
Anxiolytics and Other Agents Used to Treat Psychiatric Conditions |
|
|
632 | (33) |
|
Antianxiety Agents (Anxiolytics) |
|
|
632 | (6) |
|
Agents Used to Treat Affective Disorders |
|
|
638 | (1) |
|
|
638 | (5) |
|
|
643 | (2) |
|
|
645 | (3) |
|
Applying the Nursing Process |
|
|
648 | (10) |
|
Clients Receiving Drug Therapy for Anxiety and/or Psychiatric Conditions |
|
|
648 | (2) |
|
Clients Receiving Anxiolytics |
|
|
650 | (1) |
|
Clients Receiving Antidepressants |
|
|
651 | (2) |
|
Clients Receiving Antipsychotic Agents |
|
|
653 | (4) |
|
Clients Receiving Antimanic Agents |
|
|
657 | (1) |
|
Nursing Care Plan: A Client with Bipolar Illness Taking Lithium Carbonate |
|
|
658 | (7) |
|
Agents Used to Treat Attention-Deficit Hyperactivity Disorder and Alzheimer's Disease |
|
|
665 | (14) |
|
|
666 | (1) |
|
Atomoxetine Hydrochloride (Strattera) |
|
|
666 | (2) |
|
|
668 | (1) |
|
Agents Used to Treat Alzheimer's Disease |
|
|
668 | (3) |
|
Applying the Nursing Process |
|
|
671 | (3) |
|
Clients Receiving Central Nervous System Stimulants |
|
|
671 | (2) |
|
Clients Receiving Medications to Treat Alzheimer's Disease |
|
|
673 | (1) |
|
Nursing Care Plan: A Child with Attention-Deficit Hyperactivity Disorder Taking Atomoxetine Hydrochloride (Strattera) |
|
|
674 | (5) |
|
Agents Used in Musculoskeletal Disorders |
|
|
679 | (18) |
|
Neuromuscular Blocking Agents |
|
|
680 | (2) |
|
Centrally Acting Skeletal Muscle Relaxants |
|
|
682 | (3) |
|
Direct-Acting Skeletal Muscle Relaxants |
|
|
685 | (1) |
|
Skeletal Muscle Stimulants |
|
|
685 | (3) |
|
Applying the Nursing Process |
|
|
688 | (4) |
|
Clients Taking Neuromuscular Blocking Agents |
|
|
688 | (1) |
|
Clients Taking Centrally Acting Skeletal Muscle Relaxants |
|
|
689 | (1) |
|
Clients Taking Direct-Acting Skeletal Muscle Relaxants |
|
|
690 | (1) |
|
Clients Taking Skeletal Muscle Stimulants |
|
|
691 | (1) |
|
Nursing Care Plan: A Client with Myasthenia Gravis Taking Pyridostigmine Bromide (Mestinon) and Receiving Edrophonium Chloride (Tensilon, Reversol) |
|
|
692 | (5) |
|
|
697 | (15) |
|
|
698 | (2) |
|
|
700 | (4) |
|
Catechol-O-Methyltransferase Inhibitors |
|
|
704 | (1) |
|
Applying the Nursing Process |
|
|
704 | (2) |
|
Nursing Care Plan: A Client with Parkinson's Disease Taking Carbidopa-Levodopa (Sinemet) |
|
|
706 | (6) |
|
|
712 | (31) |
|
Applying the Nursing Process |
|
|
731 | (7) |
|
Nursing Care Plan: A Child with Epilepsy Taking Phenytoin (Dilantin) and Phenobarbital |
|
|
738 | (5) |
|
|
743 | (27) |
|
|
745 | (3) |
|
Central Nervous System Depressant Abuse |
|
|
748 | (4) |
|
Central Nervous System Stimulants |
|
|
752 | (1) |
|
|
753 | (1) |
|
|
754 | (1) |
|
|
755 | (1) |
|
|
755 | (2) |
|
|
757 | (3) |
|
Applying the Nursing Process |
|
|
760 | (6) |
|
Screening for Substance Abuse |
|
|
760 | (1) |
|
Nursing Care for Substance Abuse |
|
|
761 | (1) |
|
Nursing Care during Detoxification |
|
|
762 | (1) |
|
Treatment of Substance Abuse |
|
|
763 | (1) |
|
Impaired Health Care Workers |
|
|
763 | (1) |
|
Establishing a Drug-Free Workplace |
|
|
764 | (1) |
|
Substance Abuse Education |
|
|
764 | (2) |
|
Nursing Care Plan: A Client with Substance Abuse Receiving Naloxone Hydrochloride (Narcan) |
|
|
766 | (4) |
|
|
770 | (18) |
|
The Sympathetic Nervous System |
|
|
771 | (2) |
|
The Parasympathetic (Cholinergic) Nervous System |
|
|
773 | (1) |
|
Agents That Affect the Autonomic Nervous System |
|
|
774 | (1) |
|
Sympathomimetics (Adrenergics) |
|
|
774 | (1) |
|
Sympatholytics (Adrenergic Blockers) |
|
|
775 | (1) |
|
Parasympathomimetics (Cholinergics) |
|
|
776 | (1) |
|
Parasympatholytics (Anticholinergics) |
|
|
776 | (3) |
|
|
779 | (2) |
|
Applying the Nursing Process |
|
|
781 | (2) |
|
Nursing Care Plan: A Client with an Overactive Bladder Taking Trospium Chloride (Sanctura) |
|
|
783 | (5) |
|
SECTION 8 Agents Used to Correct Endocrine Imbalance |
|
|
|
Agents Affecting Thyroid, Parathyroid, and Pituitary Function |
|
|
788 | (25) |
|
|
789 | (5) |
|
|
794 | (2) |
|
|
796 | (2) |
|
Applying the Nursing Process |
|
|
798 | (8) |
|
Clients Taking Thyroid Medication |
|
|
798 | (3) |
|
Clients Taking Antithyroid Medication |
|
|
801 | (2) |
|
Clients Taking Medication for Parathyroid Disorders |
|
|
803 | (2) |
|
Clients Taking Pituitary Hormones |
|
|
805 | (1) |
|
Nursing Care Plan: A Client with Diabetes Insipidus Using DDAVP Spray |
|
|
806 | (7) |
|
Agents Used to Treat Hyperglycemia and Hypoglycemia |
|
|
813 | (33) |
|
|
815 | (4) |
|
|
819 | (1) |
|
|
819 | (7) |
|
Parenteral Therapy for Type 2 Diabetes |
|
|
826 | (1) |
|
Applying the Nursing Process |
|
|
827 | (11) |
|
Decreasing Deficient Knowledge |
|
|
827 | (3) |
|
Administration of Insulin by Pump |
|
|
830 | (3) |
|
Storage and Care of Insulin and Supplies |
|
|
833 | (1) |
|
|
833 | (1) |
|
Insulin Reactions and Diabetic Ketoacidosis |
|
|
834 | (2) |
|
|
836 | (1) |
|
Nursing Care for Type 2 Diabetic Clients |
|
|
837 | (1) |
|
Nursing Care Plan: A Client with Diabetes Using an Oral Hypoglycemic, Glipizide (Glucotrol) |
|
|
838 | (8) |
|
SECTION 9 Agents Affecting the Reproductive System |
|
|
|
|
846 | (28) |
|
|
847 | (7) |
|
Estrogen and Progesterone Combinations |
|
|
854 | (1) |
|
|
854 | (4) |
|
|
858 | (1) |
|
|
859 | (2) |
|
|
861 | (1) |
|
Danazol (Cyclomen, Danocrine) |
|
|
862 | (1) |
|
Nafarelin Acetate (Synarel) and Histrelin Acetate (Vantus) |
|
|
863 | (1) |
|
Leuprolide Acetate (Lupron Depot) |
|
|
863 | (1) |
|
Androgen Hormone Inhibitors |
|
|
863 | (1) |
|
Tamsulosin Hydrochloride (Flomax) |
|
|
864 | (1) |
|
Applying the Nursing Process |
|
|
864 | (4) |
|
Clients Taking Ovulation Stimulants |
|
|
867 | (1) |
|
Nursing Care Plan: A Client with Endometriosis Treated with Leuprolide Acetate (Lupron Depot) |
|
|
868 | (6) |
|
Clients Receiving Agents to Treat Erectile Dysfuntion |
|
|
870 | (4) |
|
Agents Used in Obstetrical Care |
|
|
874 | (18) |
|
|
874 | (2) |
|
|
876 | (1) |
|
|
877 | (1) |
|
|
877 | (1) |
|
Rho (D) Immune Globulin (BayRho-D, RhoGAM, MICRhoGAM, WinRho) |
|
|
878 | (1) |
|
Applying the Nursing Process |
|
|
878 | (6) |
|
Clients Taking Drugs That Influence Labor and Delivery |
|
|
878 | (1) |
|
Clients Taking Abortifacients |
|
|
879 | (2) |
|
Clients Taking Uterine Relaxants |
|
|
881 | (2) |
|
Clients Taking Lactation Suppressants or Stimulants |
|
|
883 | (1) |
|
Nursing Care Plan: A Pregnant Client Using Ritodrine Hydrochloride |
|
|
884 | (8) |
|
SECTION 10 Agents Affecting Immunity |
|
|
|
Agents That Affect Immunity |
|
|
892 | (33) |
|
Agents That Provide Active or Passive Immunity |
|
|
893 | (1) |
|
Interferons and Interleukins |
|
|
893 | (17) |
|
|
910 | (4) |
|
Antiviral Agents for Human Immunodeficiency Virus |
|
|
914 | (1) |
|
Drugs Used to Treat Gaucher's Disease |
|
|
914 | (1) |
|
Applying the Nursing Process |
|
|
915 | (3) |
|
Clients Receiving Agents to Enhance the Immune System |
|
|
915 | (2) |
|
Clients Receiving Agents to Suppress the Immune System |
|
|
917 | (1) |
|
Nursing Care Plan: A Client Receiving Muromonab-CD3 (Orthoclone OKT 3) Following Heart Transplantation |
|
|
918 | (7) |
|
Agents Used in the Treatment of Cancer |
|
|
925 | (49) |
|
|
928 | (1) |
|
|
928 | (1) |
|
|
928 | (1) |
|
|
929 | (1) |
|
|
930 | (1) |
|
|
930 | (1) |
|
|
930 | (1) |
|
Biological-Response Modifiers |
|
|
930 | (1) |
|
Miscellaneous Antineoplastic Agents |
|
|
930 | (1) |
|
|
930 | (1) |
|
|
930 | (1) |
|
|
931 | (1) |
|
|
931 | (3) |
|
|
934 | (1) |
|
Applying the Nursing Process |
|
|
934 | (30) |
|
Special Drug Delivery Methods |
|
|
958 | (5) |
|
Safe Handling of Cytotoxic Agents |
|
|
963 | (1) |
|
Nursing Care Plan: A Client Receiving Chemotherapy for Lung Cancer |
|
|
964 | (10) |
|
Clients Receiving Investigational Agents |
|
|
967 | (7) |
|
SECTION 11 Agents Used to Treat Eye, Ear, and Skin Disorders |
|
|
|
Agents Used in the Treatment of Eye Disorders |
|
|
974 | (27) |
|
|
974 | (1) |
|
Ophthalmic Anti-Infectives |
|
|
975 | (4) |
|
|
979 | (1) |
|
|
979 | (1) |
|
|
979 | (1) |
|
Nonsteroidal Anti-Inflammatory Agents |
|
|
980 | (1) |
|
|
981 | (1) |
|
|
981 | (1) |
|
Agents That Decrease the Formation of Aqueous Humor |
|
|
982 | (2) |
|
Agents That Increase the Outflow of Aqueous Humor |
|
|
984 | (2) |
|
Agents That Decrease Formation and Increase Outflow of Aqueous Humor |
|
|
986 | (2) |
|
Applying the Nursing Process |
|
|
988 | (6) |
|
|
990 | (4) |
|
Nursing Care Plan: A Client with an Eye Infection Using Vidarabine Ointment (Vira-A) |
|
|
994 | (2) |
|
Nursing Care Plan: A Client with Glaucoma Using Pilocarpine via Ocusert Therapeutic System |
|
|
996 | (5) |
|
Agents Used in the Treatment of Ear Disorders |
|
|
1001 | (9) |
|
Drugs Used in Otic Therapy |
|
|
1002 | (1) |
|
|
1002 | (2) |
|
Applying the Nursing Process |
|
|
1004 | (2) |
|
Nursing Care Plan: A Client with Otitis Media Receiving Amoxicillin/Potassium Clavulanate (Augmentin) |
|
|
1006 | (4) |
|
Agents Used in the Treatment of Skin Disorders |
|
|
1010 | (24) |
|
Drugs Used in Dermatological Therapy |
|
|
1012 | (8) |
|
|
1020 | (1) |
|
|
1020 | (1) |
|
Agents Used to Treat Eczema |
|
|
1021 | (1) |
|
Agents Used to Treat Psoriasis |
|
|
1022 | (1) |
|
Agents Used to Treat Burns |
|
|
1022 | (1) |
|
|
1022 | (1) |
|
|
1022 | (2) |
|
Applying the Nursing Process |
|
|
1024 | (4) |
|
Clients Receiving Antifungal Agents |
|
|
1025 | (2) |
|
|
1027 | (1) |
|
Nursing Care Plan: A Child with Burns Being Treated with Silver Sulfadiazine |
|
|
1028 | (6) |
Appendix 1: Nomograms for Children and Adults |
|
1034 | (2) |
Appendix 2: Diagnostic Agents |
|
1036 | (4) |
Appendix 3: Approximate Normal Values |
|
1040 | (3) |
Appendix 4: Toxicology Overview |
|
1043 | (4) |
Appendix 5: Common Food/Drug/Herbal Interactions |
|
1047 | (15) |
Appendix 6: Spanish and French Translations of Common Medication Instructions |
|
1062 | (3) |
Appendix 7: Abbreviations Commonly Found in Drug Prescriptions |
|
1065 | (2) |
Glossary |
|
1067 | (20) |
References |
|
1087 | (2) |
Index |
|
1089 | |